Verzenio 150 MG tablet UU 14S
Ended Awarded
- Contract number
- SPE2DB25FE4A9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,461
Award facts
- Contract value 100% obligated
- $15,460.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,460.60 to AmerisourceBergen Drug Corp for the supply of Verzenio 150 mg tablets (14-unit packaging) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Verzenio (abemaciclib) is a cyclins-dependent kinase 4/6 inhibitor indicated for breast cancer treatment, reflecting the scope of specialty oncology medications within the DLA Medical Supply Chain. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its critical role as a major pharmaceutical distributor for military and veteran healthcare systems, with delivery orders consistently demonstrating the company's capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FE4A9?
SPE2DB25FE4A9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FE4A9 worth?
The government has obligated $15,461 on SPE2DB25FE4A9.
Is contract SPE2DB25FE4A9 an order under another contract?
Yes. SPE2DB25FE4A9 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE4A9 competed?
The extent of competition for SPE2DB25FE4A9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award